Align Technology, Inc. (NASDAQ:ALGN) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC decreased its holdings in shares of Align Technology, Inc. (NASDAQ:ALGNFree Report) by 72.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,569 shares of the medical equipment provider’s stock after selling 6,854 shares during the period. SG Americas Securities LLC’s holdings in Align Technology were worth $704,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Morgan Stanley boosted its stake in shares of Align Technology by 9.8% during the third quarter. Morgan Stanley now owns 1,018,161 shares of the medical equipment provider’s stock worth $310,866,000 after buying an additional 90,581 shares during the period. Country Trust Bank lifted its position in Align Technology by 27.7% in the fourth quarter. Country Trust Bank now owns 80,830 shares of the medical equipment provider’s stock valued at $22,147,000 after purchasing an additional 17,515 shares during the period. Acropolis Investment Management LLC acquired a new stake in Align Technology in the third quarter valued at about $191,000. Empirical Finance LLC lifted its position in Align Technology by 10.1% in the third quarter. Empirical Finance LLC now owns 2,495 shares of the medical equipment provider’s stock valued at $762,000 after purchasing an additional 229 shares during the period. Finally, PAX Financial Group LLC lifted its position in Align Technology by 45.9% in the third quarter. PAX Financial Group LLC now owns 5,870 shares of the medical equipment provider’s stock valued at $1,792,000 after purchasing an additional 1,848 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on ALGN shares. Leerink Partnrs restated a “market perform” rating on shares of Align Technology in a research report on Monday, February 26th. Stifel Nicolaus raised their price objective on shares of Align Technology from $340.00 to $350.00 and gave the company a “buy” rating in a research report on Friday, March 15th. The Goldman Sachs Group raised their price objective on shares of Align Technology from $197.00 to $225.00 and gave the company a “sell” rating in a research report on Friday, February 2nd. Piper Sandler increased their target price on shares of Align Technology from $335.00 to $355.00 and gave the company an “overweight” rating in a report on Thursday, March 14th. Finally, SVB Leerink initiated coverage on shares of Align Technology in a report on Monday, February 26th. They issued a “market perform” rating and a $310.00 target price for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $334.45.

Get Our Latest Stock Analysis on ALGN

Insider Transactions at Align Technology

In other Align Technology news, Director Joseph Lacob sold 10,000 shares of Align Technology stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $313.01, for a total value of $3,130,100.00. Following the completion of the sale, the director now directly owns 146,994 shares of the company’s stock, valued at approximately $46,010,591.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Align Technology news, Director Joseph Lacob sold 10,000 shares of Align Technology stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $313.01, for a total value of $3,130,100.00. Following the completion of the sale, the director now directly owns 146,994 shares of the company’s stock, valued at approximately $46,010,591.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Emory Wright sold 2,524 shares of Align Technology stock in a transaction that occurred on Wednesday, February 7th. The stock was sold at an average price of $287.45, for a total transaction of $725,523.80. Following the completion of the sale, the executive vice president now directly owns 709 shares of the company’s stock, valued at $203,802.05. The disclosure for this sale can be found here. Insiders sold a total of 27,524 shares of company stock valued at $8,403,924 in the last ninety days. Corporate insiders own 0.72% of the company’s stock.

Align Technology Price Performance

Shares of ALGN opened at $312.07 on Wednesday. The firm has a 50 day simple moving average of $301.92 and a 200-day simple moving average of $269.14. Align Technology, Inc. has a 1-year low of $176.34 and a 1-year high of $413.20. The stock has a market cap of $23.44 billion, a price-to-earnings ratio of 53.62, a price-to-earnings-growth ratio of 5.90 and a beta of 1.65.

Align Technology (NASDAQ:ALGNGet Free Report) last issued its quarterly earnings data on Wednesday, January 31st. The medical equipment provider reported $1.91 earnings per share for the quarter, topping analysts’ consensus estimates of $1.78 by $0.13. Align Technology had a net margin of 11.52% and a return on equity of 13.88%. The business had revenue of $956.73 million during the quarter, compared to analysts’ expectations of $928.57 million. On average, equities analysts expect that Align Technology, Inc. will post 7.65 earnings per share for the current fiscal year.

Align Technology Company Profile

(Free Report)

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

Recommended Stories

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.